Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) had its price objective reduced by B. Riley from $4.00 to $3.00 in a research note released on Friday,Benzinga reports. They currently have ...

New York For lauded research contributions to human dendritic cell biology, including the development of Toll-like receptor agonist- and dendritic cell-based vaccines for cancer and infectious ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...

If you've ever noticed how memories from the same day seem connected while events from weeks apart feel separate, a new study ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious ...

Zika virus uses stealth. Zika virus slips into dendritic cells and blocks the dendritic cells from alerting nearby T cells to danger. It's the classic horror movie cliche -- the creeper is already in ...

How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...

Zika virus and dengue virus are very close relatives. Both are mosquito-borne flaviviruses, and both specialize in infecting ...

At this time, I would like to welcome everyone to the Lineage Cell Therapeutics Fourth Quarter and Full Year 2024 Conference Call. At this time, all participants are in a listen only mode.